Bond.az White LogoBond.az Black Logo

Kennametal Raises $700M in New Financing

Kennametal raises $700 million in new financing through a term loan and credit facility expansion to support working capital needs.

Aria Wright
ByAria Wright- Senior Editor
|
0

PITTSBURGH - Kennametal Inc. (NYSE:KMT) announced a series of financing transactions that raised $700 million in additional liquidity through a new term loan and expansion of its revolving credit facility.

The company entered into a 3-year $500 million delayed draw term loan with an interest rate of SOFR plus 112.5 basis points. The term loan allows for up to three draws through September 30, 2026, and can be prepaid at any time.

Kennametal also expanded its revolving credit facility by $200 million to $850 million using an existing accordion feature, with no changes to existing terms, pricing, covenants or maturity.

The additional liquidity supports tungsten-related working capital needs. The company also completed a $300 million offering of 5.800% senior unsecured notes maturing in 2036.

Kennametal completed a cash tender offer for $300 million of 4.625% senior notes due in 2028. Any remaining 2028 notes will be redeemed on July 1, 2026.

"These transactions position us to fund near-term working capital requirements while maintaining balance sheet discipline," said Sanjay Chowbey, President and CEO.

Kennametal generated $2 billion in revenues in fiscal 2025 and employs approximately 8,100 people.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...